IR Pharma company logo
  • Company overview
  • Meet the team
  • Why we're different;
  • Technology - The drug development process at IRP; The Drug Evaluation Process; Model systems
  • Portfolio
  • Contact us

  • 'We trust them because we know them from top to bottom'


    IR Pharma will have a presence
    at the following conferences.
    Contact us to arrange
    a meeting with one of the team.

    May 19-24, 2017
    American Thoracic Society
    Annual Conference.
    Washington DC, USA.

    September 9-13, 2017
    European Respiratory Society
    Milan, Italy.

    Case study


    What was the business challenge that led Almirall to approach IR Pharma?

    There were specific models that we did not have access to inhouse that were available via collaboration with IR Pharma so it made business sense to seek a strategic alliance between the two companies.

    What are the strengths that IR Pharma brings to the collaboration?

    Access to the models referred to above in addition to the internationally recognised expertise that the IR Pharma team can draw upon. The data that has resulted from the collaboration together with data produced inhouse on other models has facilitated decision-making processes that otherwise would not have been possible.

    How does Almirall see the collaboration going forward?

    We see IR Pharma as a complement to our internal effort in developing respiratory models that will contribute greatly to Almirall's reputation on the international stage and its commitment to producing medicines that improve public health.

    Jorge Beleta, director of discovery strategy & alliances, Almirall R&D, comments:

    'We trust them because we know them from top to bottom.'